ArticleMedical science monitor : international medical journal of experimental and clinical research2015

Serum nesfatin-1 is reduced in type 2 diabetes mellitus patients with peripheral arterial disease.

Shimei Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.